CGeneTech 

CGeneTech(Suzhou,China) Co., Ltd. is a biotechnology company in the commercialization stage, with its core product, Class 1 innovative drug Shenggliptin, on the market. The company was founded in Suzhou Industrial Park in 2010, with a core team with decades of experience in the entire lifecycle of international drugs, dedicated to the research and development and industrialization of high-quality and differentiated small molecule innovative drugs. With an integrated drug research and development technology platform and a diversified business perspective, the company has built a rich pipeline of innovative drugs covering hypoglycemic, anticancer, and autoimmune diseases.